PFE

(Bloomberg) -- Canada announced a loosening of travel restrictions for fully vaccinated people. South Africa, France and the World Health Organization are set to announce plans for Africa’s first Covid-19 vaccine facility using messenger RNA.U.K. Prime Minister Boris Johnson said England is on track for curbs to be lifted in July, while Germany warned a fourth wave is possible. Hong Kong cut its mandatory hotel quarantine in half for international travelers from most places.Cases surged in Indon

New Zealand has tentatively cleared the COVID-19 vaccine that Pfizer (PFE) developed in partnership with BioNTech (BNTX) for 12-15-year olds, according to a Reuters report. “After careful consideration of the most up-to-date scientific and medical data available, Medsafe has announced provisional approval for our young people to be given the Pfizer vaccine,” Reuters quoted PM Jacinda Ardern as saying. Medsafe is New Zealand’s drugs regulator. The country has more than 250,000 children aged 12 -

The new variant of COVID-19 virus, delta, is increasing the risk of infections across the globe. This will likely lead to higher demand for COVID-19 vaccines and therapeutics.

India's government is in talks with Pfizer and other vaccine manufacturers for import of their COVID-19 vaccines in accordance with local laws, a senior government official said on Monday. Any final decision on vaccine imports has to be compatible with Indian laws and the government was hopeful that these vaccines would be available in the country before the end of this year, Paul said.

(Bloomberg) -- China will risk international isolation if it fails to allow a “real” investigation on its territory into the origins of the virus that caused the pandemic, U.S. National Security Adviser Jake Sullivan said. President Joe Biden is traveling to North Carolina on Thursday to encourage more Americans to get vaccinated.Russia, Germany and Portugal reported an expanding spread of the highly transmissible delta variant that first appeared in India. Scott Gottlieb, a former head of the U

The Philippine government has signed a supply agreement for 40 million doses of the COVID-19 vaccine developed by Pfizer Inc and BioNTech SE, in its biggest coronavirus vaccine deal to date. Deliveries of the vaccine will begin in late September, Carlito Galvez, head of the government's COVID-19 vaccine procurement, said on Sunday. The Philippines has now ordered 113 million doses from five vaccine manufacturers, including 26 million from China's Sinovac , 10 million of Russia's Sputnik V, 20 million doses from Moderna and 17 million doses from AstraZeneca.

Switzerland plans to allow 12- to 15-year olds to receive vaccinations against COVID-19 as soon as next week, government vaccine chief Christoph Berger told Swiss newspaper NZZ in an interview published on Sunday. "Young people who want to be vaccinated should be given the opportunity," Berger told NZZ, adding the government's approval was expected to be communicated next week. "For those with pre-existing conditions or those in contact with immunocompromised individuals who are at risk, vaccination makes sense," he said, adding that - unlike for older populations - it would not be necessary to target a vaccination rate for the 12- to 15-year old population.

COVID-19 vaccines delivered by Israel and then rejected by the Palestinian Authority (PA) over their expiration date were fine, the Israeli health ministry said on Saturday. Israel and the PA on Friday announced a vaccine swap deal that would have seen Israel send up to 1.4 million doses of the vaccine made jointly by Pfizer (PFE.N) and BioNTech (22UAy.DE) to the PA in exchange for receiving a reciprocal number of doses later this year. But soon after the announcement, the PA cancelled the deal and said it had sent an initial shipment of around 90,000 doses back to Israel.

Indonesia will receive 50 million doses of the COVID-19 vaccine jointly made by Pfizer (PFE.N) and BioNTech (22UAy.DE), with the first batch expected in August, a senior health ministry official said on Saturday. "Pfizer vaccines will start arriving from August, with shipments of between 7.5 million to 12 million doses per month,” said Siti Nadia Tarmizi, adding that the supply is the result of a direct government purchase. The Southeast Asia's biggest country is grappling with a fresh increase in coronavirus infections in recent weeks.

When they did -- thanks to Pfizer, BioNTech, and Moderna -- the results were much better than most had hoped for. The Pfizer-BioNTech drug -- now marketed as Comirnaty -- was the first to share phase 3 data. Moderna followed two weeks later with its own impressive results.

It hasn't been a secret that the COVID-19 vaccines developed by Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) are highly effective. In this Motley Fool Live video recorded on June 9, Motley Fool contributors Keith Speights and Brian Orelli discuss what investors should make of the latest CDC data.

Pfizer has recently announced that the company has named Ramcess Jean-Louis, Esq. as Global Chief Diversity, Equity, and Inclusion (DEI) Officer

Jun.18 -- Pfizer Chairman and CEO Albert Bourla says the out-of-pocket drug costs now paid by U.S. patients “is something that needs to be fixed" and suggests President Joe Biden form a bipartisan coalition in Washington to address the problem. Bourla speaks to Bloomberg's David Westin on "Balance of Power."

Pfizer stock briefly broke out in May after the company called for $26 billion in full-year coronavirus vaccine sales. Is PFE stock a buy right now?

AstraZeneca's (AZN) phase III study on COVID-19 antibody cocktail fails to meet primary goal. Glaxo (GSK) signs a new co-development/commercialization deal for a cancer candidate with iTeos Therapeutics.

The European Commission already has signed an advance purchase agreement for as many as 405 million doses from the company. "Demonstrating high efficacy in this unprecedented broad diversity of variants is challenging," CureVac CEO Franz-Werner Haas said when reporting the interim trial analysis.

Shares of Curevac rose 10% in premarket trading on Friday. Shares of the German biotech have lost 48% this week after the company said a late-stage clinical trial of its COVID-19 vaccine was only 47% effective . But Curevac's chief financial officer, Pierre Kemula, said the company hopes its candidate can still be of use, when a final analysis is done, with that data just two or three weeks away. "We need to look at the data and see, OK, what would be the best value, how we can place this vaccin

Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE) have remained a step ahead of most potential coronavirus vaccine rivals. Novavax (NASDAQ: NVAX) plans to submit its coronavirus vaccine candidate for emergency authorization in various countries including the U.S. in the third quarter. Now the question is whether Novavax has what it takes to join leaders Pfizer and Moderna at the top.

The Palestinian Authority (PA) cancelled a deal on Friday to receive soon-to-expire COVID-19 vaccines from Israel after an initial Israeli shipment showed an expiration date sooner than had been agreed, the PA health minister said. Israel and the PA announced a vaccine swap deal earlier on Friday that would have seen Israel send up to 1.4 million Pfizer-BioNTech doses to the PA, in exchange for receiving a reciprocal number of doses from the PA later this year.

Some 760,000 South Koreans who have received a first dose of AstraZeneca Plc's COVID-19 vaccine will be offered Pfizer Inc's vaccine as a second shot due to shipment delays by global vaccine sharing scheme COVAX, the government said. Several countries, including Canada and Spain, have already approved such dose-mixing mainly due to concerns about rare and potentially fatal blood clots linked to the AstraZeneca vaccine. A Spanish study found that giving a dose of the Pfizer shot to people who already received the AstraZeneca vaccine is highly safe and effective, according to preliminary results.